Multi-Center, Open-Label, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 20 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 26 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
- 06 Dec 2016 Results (data cut off, 31 March 2016) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History